Immix Biopharma, Inc. (IMMX) stock
IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.84−0.23 (-2.85%)
Close on Nov 13, 2026Market cap $560.87MP/E –Yield –
Immix Biopharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Immix Biopharma's enterprise value was $387.40M on Nov 11, 2026, against $124.45M a year earlier. Over the last 5 years it ranged from -$4.49M to $771.55M, with a median of $34.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $387.40M | +147.0% |
| 2025 | Dec 31, 2025 | $156.83M | +284.7% |
| 2024 | Dec 31, 2024 | $40.77M | -64.9% |
| 2023 | Dec 29, 2023 | $115.99M | +674.5% |
| 2022 | Dec 30, 2022 | $14.98M | +28.8% |
| 2021 | Dec 31, 2021 | $11.62M | – |
See a number that looks wrong?